Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily attacks the joints, causing painful swelling, stiffness, and progressive joint damage. Unlike osteoarthritis, RA is caused by the immune system mistakenly attacking joint tissue. Without treatment, RA can cause permanent joint deformity and disability.
You may qualify for clinical trials that provide Humira at no cost
Clinical trials may give you access to this treatment while helping advance medical research
Search TrialsInsurers universally require trial of methotrexate (≥15mg/week for ≥3 months) before approving biologic therapy. Most also require failure of at least one additional conventional DMARD (hydroxychloroquine, sulfasalazine, or leflunomide). Biosimilar adalimumab or infliximab is typically required before brand biologics. JAK inhibitors (Rinvoq, Xeljanz) are restricted to post-biologic failure.
Must fail methotrexate plus another DMARD before biologic therapy
Very Common
Biosimilar preferred over brand biologic (Humira → adalimumab biosimilar)
Common
Missing rheumatoid factor (RF) or anti-CCP antibody documentation
Common
Disease activity scores (DAS28) not documented
Occasional
JAK inhibitor denied due to FDA black-box warning restrictions
Occasional
- 1.Document all DMARD trials with specific dates, doses, duration, and reasons for failure
- 2.Include DAS28, CDAI, or SDAI disease activity scores
- 3.Submit RF and anti-CCP antibody results; include inflammatory markers (CRP, ESR)
- 4.For biosimilar switch denials, document treatment stability on current brand biologic
- 5.Cite ACR guidelines supporting treat-to-target strategy and biologic use in moderate-to-severe RA
Active clinical trials that may provide treatment at no cost.
Copay cards, patient assistance programs, and foundation grants for this condition's treatments.
Want to know what you'll actually pay?
Estimate your annual out-of-pocket cost with and without assistance programs.
Estimate My CostsDenied for Rheumatoid Arthritis Treatment?
Ellen can decode your denial, find your appeal strategy, and generate your appeal letter — free.